Bendroflumethiazide-d7
Bendroflumethiazide-d7 (Bendrofluazide-d7) is deuterium labeled Bendroflumethiazide (HY-B1363) . Bendroflumethiazide (Bendrofluazide) is an orally available diuretic. Bendroflumethiazide inhibits the electroneutral sodium-chloride symporter located in the apical membrane of the early segment of the distal convoluted tubule and can effectively lower blood pressure. Bendroflumethiazide is used in the study of hypertension and edema. Bendroflumethiazide has an antidiuretic effect in diabetes insipidus[1][2][3].
Product Specifications
Product Name Alternative
Bendrofluazide-d7
UNSPSC
12352005
Target
Isotope-Labeled Compounds; NKCC
Related Pathways
Membrane Transporter/Ion Channel; Others
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Smiles
O=S(C1=C(C(F)(F)F)C=C(C2=C1)NC(C([2H])([2H])C3=C([2H])C([2H])=C([2H])C([2H])=C3[2H])NS2(=O)=O)(N)=O
Molecular Formula
C15H7D7F3N3O4S2
Molecular Weight
428.46
References & Citations
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-B1363S1/
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Rabbit anti-Escherichia coli O1:K1/APEC EUTC Polyclonal Antibody
Recombinant Human Killer Cell Immunoglobulin Like Receptor 2DL2 (KIR2DL2)
Recombinant Human Killer Cell Immunoglobulin Like Receptor 2DL2 (KIR2DL2)